Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease

2017214 citationsJournal Article

Authors

Good health and well-being

Published in: Gastroenterology

Volume 152, Issue 8, pp. 1901-1914.e3

Field-Weighted Citation Impact: 21.00